Sandrijne Lambrechts
Sandrijne Lambrechts
Mumc maastricht
Verified email at
Cited by
Cited by
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ...
Nature genetics 45 (4), 362-370, 2013
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+ CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
D Chen, Y Zhang, J Wang, J Chen, C Yang, K Cai, X Wang, F Shi, J Dou
Journal of ovarian research 6 (1), 1-11, 2013
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ...
Nature communications 4 (1), 1-10, 2013
Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome
I Kalogiannidis, S Lambrechts, F Amant, P Neven, T Van Gorp, I Vergote
American journal of obstetrics and gynecology 196 (3), 248. e1-248. e8, 2007
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
AE Teschendorff, SH Lee, A Jones, H Fiegl, M Kalwa, W Wagner, ...
Genome medicine 7 (1), 1-12, 2015
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21. 31
J Permuth-Wey, K Lawrenson, HC Shen, A Velkova, JP Tyrer, Z Chen, ...
Nature communications 4 (1), 1-12, 2013
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
CM Nagle, SC Dixon, A Jensen, SK Kjaer, F Modugno, A DeFazio, ...
British journal of cancer 113 (5), 817-826, 2015
ABCA transporter gene expression and poor outcome in epithelial ovarian cancer
EL Hedditch, B Gao, AJ Russell, Y Lu, C Emmanuel, J Beesley, ...
JNCI: Journal of the National Cancer Institute 106 (7), 2014
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment
E Despierre, D Lambrechts, P Neven, F Amant, S Lambrechts, I Vergote
Gynecologic oncology 117 (2), 358-365, 2010
Genome-wide significant risk associations for mucinous ovarian carcinoma
LE Kelemen, K Lawrenson, J Tyrer, Q Li, JM Lee, JH Seo, CM Phelan, ...
Nature genetics 47 (8), 888, 2015
BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients–a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)
I Ruscito, D Dimitrova, I Vasconcelos, K Gellhaus, T Schwachula, F Bellati, ...
European journal of cancer 50 (12), 2090-2098, 2014
Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy
E Despierre, S Lambrechts, K Leunen, P Berteloot, P Neven, F Amant, ...
Gynecologic oncology 130 (1), 192-199, 2013
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients-a study of the OVCAD consortium
A Bachmayr-Heyda, S Aust, G Heinze, S Polterauer, C Grimm, EI Braicu, ...
BMC cancer 13 (1), 422, 2013
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
SE Johnatty, J Beesley, B Gao, X Chen, Y Lu, MH Law, MJ Henderson, ...
Gynecologic oncology 131 (1), 8-14, 2013
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers
J Beesley, HA Pickett, SE Johnatty, AM Dunning, X Chen, J Li, ...
PloS one 6 (9), e24987, 2011
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study
SC Dixon, CM Nagle, AP Thrift, PDP Pharoah, CL Pearce, W Zheng, ...
International journal of epidemiology 45 (3), 884-895, 2016
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients–A study of the OVCAD consortium
D Pils, A Bachmayr-Heyda, K Auer, M Svoboda, V Auner, G Hager, ...
European journal of cancer 50 (1), 99-110, 2014
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
F Trillsch, L Woelber, C Eulenburg, I Braicu, S Lambrechts, R Chekerov, ...
Journal of ovarian research 6 (1), 42, 2013
The system can't perform the operation now. Try again later.
Articles 1–20